EP0842657A1
(de)
*
|
1996-11-19 |
1998-05-20 |
OctoPlus B.V. |
Mikrosphären zur gesteuerten Freisetzung und Verfahren zur Herstellung dieser Mikrosphären
|
FR2777895A1
(fr)
*
|
1998-04-28 |
1999-10-29 |
Debio Rech Pharma Sa |
Polymere sequence non-reticule,procede pour sa preparation, et ses utilisations
|
US6264991B1
(en)
*
|
1998-08-18 |
2001-07-24 |
Southern Research Institute |
Compositions and methods for treating intracellular infections
|
US6656489B1
(en)
|
1999-02-10 |
2003-12-02 |
Isotis N.V. |
Scaffold for tissue engineering cartilage having outer surface layers of copolymer and ceramic material
|
EP1038538A1
(de)
*
|
1999-03-19 |
2000-09-27 |
IsoTis B.V. |
Verfahren zur Regeneration von Muskelgewebe
|
ATE244558T1
(de)
*
|
1999-04-16 |
2003-07-15 |
Novo Nordisk As |
Trockene formbare arzneistoffformulierung
|
AU4518400A
(en)
*
|
1999-07-12 |
2001-01-18 |
Isotis B.V. |
Sutures
|
EP1068872A1
(de)
*
|
1999-07-12 |
2001-01-17 |
IsoTis B.V. |
Nahtmaterialen
|
WO2001010414A1
(en)
*
|
1999-08-04 |
2001-02-15 |
Oakwood Laboratories L.L.C. |
Slow release microspheres
|
EP1902738B1
(de)
*
|
1999-08-06 |
2009-12-30 |
Chienna B.V. |
Formung eines Polymers
|
CA2321321A1
(en)
|
1999-09-30 |
2001-03-30 |
Isotis B.V. |
Polymers loaded with bioactive agents
|
EP1090928B1
(de)
*
|
1999-09-30 |
2004-05-26 |
Chienna B.V. |
Mit bioaktiven Mitteln beladene Polymeren
|
US20050214327A1
(en)
*
|
2000-06-02 |
2005-09-29 |
Allergan, Inc. |
Neurotoxin-containing suppositories and related methods
|
US6306423B1
(en)
|
2000-06-02 |
2001-10-23 |
Allergan Sales, Inc. |
Neurotoxin implant
|
US20040170665A1
(en)
*
|
2000-06-02 |
2004-09-02 |
Allergan, Inc. |
Intravitreal botulinum toxin implant
|
US20040033241A1
(en)
*
|
2000-06-02 |
2004-02-19 |
Allergan, Inc. |
Controlled release botulinum toxin system
|
DE60127139T2
(de)
*
|
2000-07-14 |
2007-12-13 |
Novo Nordisk A/S |
Verfahren zum formen einer pharmazeutischen zusammensetzung in einem verpackungsmaterial
|
EP1247537A1
(de)
*
|
2001-04-04 |
2002-10-09 |
Isotis B.V. |
Beschichtung für medizinische Vorrichtungen
|
US6565884B2
(en)
|
2001-09-10 |
2003-05-20 |
Interpore Cross International |
Bone graft material incorporating demineralized bone matrix and lipids
|
US7357947B2
(en)
*
|
2001-09-10 |
2008-04-15 |
Biomet, Inc. |
Bone graft material incorporating demineralized bone matrix and lipids
|
WO2003041689A1
(en)
*
|
2001-11-12 |
2003-05-22 |
Alkermes Controlled Therapeutics, Inc. |
Biocompatible polymer blends and uses thereof
|
US8454997B2
(en)
|
2001-12-18 |
2013-06-04 |
Novo Nordisk A/S |
Solid dose micro implant
|
ATE335035T1
(de)
*
|
2002-02-26 |
2006-08-15 |
Chienna Bv |
Bioabbaubares polymermaterial für biomedizinische anwendungen
|
ES2665999T3
(es)
*
|
2002-05-31 |
2018-04-30 |
Titan Pharmaceuticals, Inc. |
Dispositivo polimérico implantable para la liberación sostenida de buprenorfina
|
AU2003249244A1
(en)
*
|
2002-07-15 |
2004-02-02 |
Combinatorx, Incorporated |
Methods for the treatment of neoplasms
|
US6926919B1
(en)
*
|
2003-02-26 |
2005-08-09 |
Advanced Cardiovascular Systems, Inc. |
Method for fabricating a coating for a medical device
|
PL1610791T3
(pl)
|
2003-03-31 |
2011-07-29 |
Titan Pharmaceuticals Inc |
Wszczepialne urządzenie polimerowe do przedłużonego uwalniania agonisty dopaminy
|
FR2861734B1
(fr)
|
2003-04-10 |
2006-04-14 |
Corneal Ind |
Reticulation de polysaccharides de faible et forte masse moleculaire; preparation d'hydrogels monophasiques injectables; polysaccharides et hydrogels obtenus
|
US20040215318A1
(en)
*
|
2003-04-24 |
2004-10-28 |
Brian Kwitkin |
Timed delivery of therapeutics to blood vessels
|
US7387793B2
(en)
|
2003-11-14 |
2008-06-17 |
Eurand, Inc. |
Modified release dosage forms of skeletal muscle relaxants
|
JP4889505B2
(ja)
|
2004-02-02 |
2012-03-07 |
アンブレツクス・インコーポレイテツド |
被修飾されたヒト成長ホルモンポリペプチドおよびこれらの使用
|
EP1789088A4
(de)
*
|
2004-03-24 |
2009-12-30 |
Doctor S Res Group Inc |
Verfahren zur durchführung von medizinischen verfahren zur förderung des knochenwachstums, verfahren zur herstellung von zusammensetzungen zur förderung des knochenwachstums und gerät zur verwendung bei solchen verfahren
|
EP2329852A1
(de)
|
2004-03-26 |
2011-06-08 |
SurModics, Inc. |
Zusammensetzung und Verfahren zur Herstellung von biokompatiblen Oberflächen
|
JP2008503217A
(ja)
|
2004-06-18 |
2008-02-07 |
アンブレツクス・インコーポレイテツド |
新規抗原結合ポリペプチド及びそれらの使用
|
US20060024350A1
(en)
*
|
2004-06-24 |
2006-02-02 |
Varner Signe E |
Biodegradable ocular devices, methods and systems
|
US20060018948A1
(en)
*
|
2004-06-24 |
2006-01-26 |
Guire Patrick E |
Biodegradable implantable medical devices, methods and systems
|
WO2009100255A2
(en)
|
2008-02-08 |
2009-08-13 |
Ambrx, Inc. |
Modified leptin polypeptides and their uses
|
CA2569381A1
(en)
|
2004-07-21 |
2006-08-31 |
Ambrx, Inc. |
Biosynthetic polypeptides utilizing non-naturally encoded amino acids
|
US7311980B1
(en)
*
|
2004-08-02 |
2007-12-25 |
Advanced Cardiovascular Systems, Inc. |
Polyactive/polylactic acid coatings for an implantable device
|
US20060073208A1
(en)
*
|
2004-10-01 |
2006-04-06 |
Allergan, Inc. |
Cosmetic neurotoxin compositions and methods
|
GB0426823D0
(en)
|
2004-12-07 |
2005-01-12 |
Precisense As |
Sensor for detection of glucose
|
GB0426822D0
(en)
|
2004-12-07 |
2005-01-12 |
Precisense As |
Sensor for detection of glucose
|
WO2006068802A2
(en)
|
2004-12-22 |
2006-06-29 |
Ambrx, Inc. |
COMPOSITIONS OF AMINOACYL-tRNA SYNTHETASE AND USES THEREOF
|
KR101224781B1
(ko)
|
2004-12-22 |
2013-01-21 |
암브룩스, 인코포레이티드 |
비천연적으로 코딩된 아미노산을 포함하는 인간 성장호르몬의 조제물
|
JP2008525032A
(ja)
*
|
2004-12-22 |
2008-07-17 |
アンブレツクス・インコーポレイテツド |
組換えヒト成長ホルモンを発現及び精製するための方法
|
KR20070090023A
(ko)
|
2004-12-22 |
2007-09-04 |
암브룩스, 인코포레이티드 |
변형 인간 성장 호르몬
|
US20060147491A1
(en)
*
|
2005-01-05 |
2006-07-06 |
Dewitt David M |
Biodegradable coating compositions including multiple layers
|
US20060198868A1
(en)
*
|
2005-01-05 |
2006-09-07 |
Dewitt David M |
Biodegradable coating compositions comprising blends
|
EP1679065A1
(de)
|
2005-01-07 |
2006-07-12 |
OctoPlus Sciences B.V. |
Zubereitung mit kontrollierter Freisetzung von Interferon auf PEGT/PBT-Block-Copolymer-Basis
|
CA2609205A1
(en)
*
|
2005-06-03 |
2006-12-14 |
Ambrx, Inc. |
Improved human interferon molecules and their uses
|
AU2005335491B2
(en)
|
2005-08-18 |
2010-11-25 |
Ambrx, Inc. |
Compositions of tRNA and uses thereof
|
ATE500215T1
(de)
*
|
2005-11-08 |
2011-03-15 |
Ambrx Inc |
Beschleuniger für die modifikation nichtnatürlicher aminosäuren und nichtnatürlicher aminosäurepolypeptide
|
ES2547554T3
(es)
*
|
2005-11-16 |
2015-10-07 |
Ambrx, Inc. |
Métodos y composiciones que comprenden aminoácidos no naturales
|
WO2007061896A1
(en)
|
2005-11-17 |
2007-05-31 |
Zogenix, Inc. |
Delivery of viscous formulations by needle-free injection
|
KR101423898B1
(ko)
*
|
2005-12-14 |
2014-07-28 |
암브룩스, 인코포레이티드 |
비-천연 아미노산 및 폴리펩티드를 함유하는 조성물, 비-천연 아미노산 및 폴리펩티드를 포함하는 방법, 및 비-천연 아미노산 및 폴리펩티드의 용도
|
US7756524B1
(en)
|
2006-01-31 |
2010-07-13 |
Nextel Communications Inc. |
System and method for partially count-based allocation of vocoder resources
|
EP2037977A2
(de)
*
|
2006-06-28 |
2009-03-25 |
SurModics, Inc. |
Wirkstoffbeschichtete matrizen mit partikeln
|
EP2069396B1
(de)
|
2006-09-08 |
2015-10-21 |
Ambrx, Inc. |
Modifiziertes polypeptid oder fc-gerüste aus humanem plasma und ihre verwendung
|
CN101541955B
(zh)
*
|
2006-09-08 |
2016-09-28 |
Ambrx公司 |
用于脊椎动物细胞的杂合抑制tRNA
|
PT2064333E
(pt)
*
|
2006-09-08 |
2014-06-09 |
Ambrx Inc |
Supressor híbrido arnt para células de vertebrados
|
US20080138397A1
(en)
*
|
2006-10-24 |
2008-06-12 |
Aradigm Corporation |
Processes for taste-masking of inhaled formulations
|
US20080154241A1
(en)
*
|
2006-12-07 |
2008-06-26 |
Burkstrand Michael J |
Latent stabilization of bioactive agents releasable from implantable medical articles
|
PL2068909T3
(pl)
|
2007-03-30 |
2012-09-28 |
Ambrx Inc |
Modyfikowane polipeptydy fgf-21 i ich zastosowanie
|
EP2076533B1
(de)
|
2007-05-02 |
2014-10-08 |
Ambrx, Inc. |
Modifizierte interferon-beta-polypeptide und ihre verwendungen
|
BRPI0811784A2
(pt)
|
2007-05-23 |
2011-05-10 |
Allergan Inc |
colÁgeno reticulado e uso do mesmo
|
WO2009005709A1
(en)
*
|
2007-06-28 |
2009-01-08 |
Surmodics, Inc. |
Polypeptide microparticles
|
WO2009005718A1
(en)
*
|
2007-06-28 |
2009-01-08 |
Surmodics, Inc. |
Polypeptide microparticles having sustained release characteristics, methods and uses
|
WO2009015336A2
(en)
*
|
2007-07-25 |
2009-01-29 |
Biolex Therapeutics, Inc. |
Controlled release interferon drug products and treatment of hcv infection using same
|
US8318695B2
(en)
|
2007-07-30 |
2012-11-27 |
Allergan, Inc. |
Tunably crosslinked polysaccharide compositions
|
US9138509B2
(en)
*
|
2007-09-14 |
2015-09-22 |
Musculoskeletal Transplant Foundation |
Composition for filling bone defects
|
US8697044B2
(en)
|
2007-10-09 |
2014-04-15 |
Allergan, Inc. |
Crossed-linked hyaluronic acid and collagen and uses thereof
|
EP2055299A1
(de)
*
|
2007-10-23 |
2009-05-06 |
Koninklijke Philips Electronics N.V. |
Verfahren zur Herstellung von Polymermikropartikeln
|
EP2818184B1
(de)
|
2007-11-16 |
2018-10-31 |
Allergan, Inc. |
Zusammensetzungen Und Verfahren Zur Behandlung Von Purpura
|
ES2632504T3
(es)
|
2007-11-20 |
2017-09-13 |
Ambrx, Inc. |
Polipéptidos de insulina modificados y sus usos
|
US20090143348A1
(en)
*
|
2007-11-30 |
2009-06-04 |
Ahmet Tezel |
Polysaccharide gel compositions and methods for sustained delivery of drugs
|
US8394784B2
(en)
|
2007-11-30 |
2013-03-12 |
Allergan, Inc. |
Polysaccharide gel formulation having multi-stage bioactive agent delivery
|
US8394782B2
(en)
|
2007-11-30 |
2013-03-12 |
Allergan, Inc. |
Polysaccharide gel formulation having increased longevity
|
EP2235266A1
(de)
*
|
2007-12-21 |
2010-10-06 |
3M Innovative Properties Company |
Rückstrahlende strassenmarkierungen
|
DE102007062113B4
(de)
*
|
2007-12-21 |
2011-05-12 |
Bettina Lingenfelder |
Dermatologische Zubereitung
|
US9314524B2
(en)
*
|
2007-12-31 |
2016-04-19 |
Calla Therapeutics Llc |
Topical formulations of Flucytosine
|
US20090186059A1
(en)
*
|
2008-01-14 |
2009-07-23 |
Johnson Elizabeth E |
Devices and methods for elution of nucleic acid delivery complexes
|
WO2009120361A2
(en)
|
2008-03-28 |
2009-10-01 |
Surmodics, Inc. |
Insertable medical devices having microparticulate-associated elastic substrates and methods for drug delivery
|
WO2009126830A2
(en)
*
|
2008-04-09 |
2009-10-15 |
Surmodics, Inc. |
Delivery of nucleic acid complexes from materials including negatively charged groups
|
EP2265293B1
(de)
*
|
2008-04-18 |
2015-11-04 |
SurModics, Inc. |
Beschichtungssysteme zur gesteuerten freisetzung hydrophiler biowirkstoffe
|
JP2011518881A
(ja)
|
2008-04-28 |
2011-06-30 |
ゾゲニクス インコーポレーティッド |
片頭痛の治療のための製剤
|
CA2723192A1
(en)
*
|
2008-05-07 |
2009-11-12 |
Surmodics, Inc. |
Delivery of nucleic acid complexes from particles
|
US20100008966A1
(en)
*
|
2008-07-14 |
2010-01-14 |
Surmodics, Inc. |
Medical Devices and Methods for Delivery of Nucleic Acids
|
JP5680534B2
(ja)
|
2008-07-23 |
2015-03-04 |
イーライ リリー アンド カンパニー |
修飾されているウシg−csfポリペプチドおよびそれらの使用
|
US8357795B2
(en)
|
2008-08-04 |
2013-01-22 |
Allergan, Inc. |
Hyaluronic acid-based gels including lidocaine
|
CA2735173C
(en)
|
2008-09-02 |
2017-01-10 |
Tautona Group Lp |
Threads of hyaluronic acid and/or derivatives thereof, methods of making thereof and uses thereof
|
US8283165B2
(en)
|
2008-09-12 |
2012-10-09 |
Genvault Corporation |
Matrices and media for storage and stabilization of biomolecules
|
PE20110832A1
(es)
|
2008-09-26 |
2011-11-24 |
Ambrx Inc |
Polipeptidos de eritropoyetina felina modificados
|
MX348657B
(es)
|
2008-09-26 |
2017-06-21 |
Ambrx Inc |
Microorganismos y vacunas dependientes de replicacion de aminoacidos no naturales.
|
US8883208B2
(en)
*
|
2009-04-08 |
2014-11-11 |
Surmodics, Inc. |
Particles for delivery of nucleic acids and related devices and methods
|
CA2758260A1
(en)
*
|
2009-04-08 |
2010-10-14 |
Surmodics, Inc. |
Controlled release devices and methods for delivery of nucleic acids
|
US8246576B2
(en)
|
2009-05-18 |
2012-08-21 |
Surmodics, Inc. |
Method and apparatus for delivery of a therapeutic agent with an expandable medical device
|
CN102666578A
(zh)
|
2009-12-21 |
2012-09-12 |
Ambrx公司 |
经过修饰的猪促生长素多肽和其用途
|
EA201290541A1
(ru)
|
2009-12-21 |
2013-05-30 |
Амбркс, Инк. |
Модифицированные бычьи соматотропиновые полипептиды и их применение
|
US20110159098A1
(en)
*
|
2009-12-30 |
2011-06-30 |
Surmodics, Inc. |
Stabilization and delivery of nucleic acid complexes
|
US20110172180A1
(en)
|
2010-01-13 |
2011-07-14 |
Allergan Industrie. Sas |
Heat stable hyaluronic acid compositions for dermatological use
|
US9114188B2
(en)
|
2010-01-13 |
2015-08-25 |
Allergan, Industrie, S.A.S. |
Stable hydrogel compositions including additives
|
NZ602405A
(en)
|
2010-03-12 |
2014-12-24 |
Allergan Ind Sas |
A fluid composition comprising a hyaluronan polymer and mannitol for improving skin conditions
|
DK2550027T4
(da)
|
2010-03-22 |
2019-05-13 |
Allergan Inc |
Tværbundne polysaccharid- og protein-polysaccharid-hydrogeler til blødvævsforøgelse
|
US20110319473A1
(en)
|
2010-06-29 |
2011-12-29 |
Surmodics, Inc. |
Compositions and methods for enhancement of nucleic acid delivery
|
PL2859887T3
(pl)
|
2010-07-09 |
2017-10-31 |
Innocore Tech B V |
Biodegradowalne segmentowane kopolimery wieloblokowe z rozdziałem faz oraz uwalnianie biologicznie czynnych polipeptydów
|
US9567386B2
(en)
|
2010-08-17 |
2017-02-14 |
Ambrx, Inc. |
Therapeutic uses of modified relaxin polypeptides
|
CA2808596C
(en)
|
2010-08-17 |
2020-12-15 |
Ambrx, Inc. |
Modified relaxin polypeptides and their uses
|
US8883139B2
(en)
|
2010-08-19 |
2014-11-11 |
Allergan Inc. |
Compositions and soft tissue replacement methods
|
US9005605B2
(en)
|
2010-08-19 |
2015-04-14 |
Allergan, Inc. |
Compositions and soft tissue replacement methods
|
US8889123B2
(en)
|
2010-08-19 |
2014-11-18 |
Allergan, Inc. |
Compositions and soft tissue replacement methods
|
US8697057B2
(en)
|
2010-08-19 |
2014-04-15 |
Allergan, Inc. |
Compositions and soft tissue replacement methods
|
AR083006A1
(es)
|
2010-09-23 |
2013-01-23 |
Lilly Co Eli |
Formulaciones para el factor estimulante de colonias de granulocitos (g-csf) bovino y variantes de las mismas
|
EP2621475A1
(de)
|
2010-10-02 |
2013-08-07 |
Link Research&Grants Corporation |
Behandlung von tinnitus und zugehörigen dysfunktionen des gehörs
|
US20120100187A1
(en)
|
2010-10-26 |
2012-04-26 |
Surmodics, Inc. |
Coatings and methods for controlled elution of hydrophilic active agents
|
US8901092B2
(en)
|
2010-12-29 |
2014-12-02 |
Surmodics, Inc. |
Functionalized polysaccharides for active agent delivery
|
US9861727B2
(en)
|
2011-05-20 |
2018-01-09 |
Surmodics, Inc. |
Delivery of hydrophobic active agent particles
|
FR2975301B1
(fr)
*
|
2011-05-20 |
2013-05-24 |
Flamel Tech Sa |
Composition comprenant un interferon alpha
|
US10213529B2
(en)
|
2011-05-20 |
2019-02-26 |
Surmodics, Inc. |
Delivery of coated hydrophobic active agent particles
|
EP2714002B1
(de)
|
2011-06-03 |
2019-04-03 |
Allergan, Inc. |
Dermale füllstoffzusammensetzungen mit antioxidantien
|
US9393263B2
(en)
|
2011-06-03 |
2016-07-19 |
Allergan, Inc. |
Dermal filler compositions including antioxidants
|
US20130096081A1
(en)
|
2011-06-03 |
2013-04-18 |
Allergan, Inc. |
Dermal filler compositions
|
US9408797B2
(en)
|
2011-06-03 |
2016-08-09 |
Allergan, Inc. |
Dermal filler compositions for fine line treatment
|
JP2014523914A
(ja)
|
2011-07-18 |
2014-09-18 |
プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ |
操作された微生物標的化分子およびその使用
|
KR101889586B1
(ko)
|
2011-07-22 |
2018-09-20 |
이노코어 테크놀로지스 비.브이. |
생물학적 활성 화합물의 조절된 방출을 위한 생분해성, 반-결정, 상 분리, 열 가소성 플라스틱의 멀티-블록 공중합체
|
US20130244943A1
(en)
|
2011-09-06 |
2013-09-19 |
Allergan, Inc. |
Hyaluronic acid-collagen matrices for dermal filling and volumizing applications
|
US9662422B2
(en)
|
2011-09-06 |
2017-05-30 |
Allergan, Inc. |
Crosslinked hyaluronic acid-collagen gels for improving tissue graft viability and soft tissue augmentation
|
JP6498600B2
(ja)
|
2012-06-08 |
2019-04-10 |
ストロ バイオファーマ インコーポレーテッド |
部位特異的な非天然アミノ酸残基を含む抗体、その調製方法、及びその使用方法
|
US9732161B2
(en)
|
2012-06-26 |
2017-08-15 |
Sutro Biopharma, Inc. |
Modified Fc proteins comprising site-specific non-natural amino acid residues, conjugates of the same, methods of their preparation and methods of their use
|
CN104981254B
(zh)
|
2012-08-31 |
2018-05-22 |
苏特罗生物制药公司 |
含有叠氮基的经修饰的氨基酸
|
US11246963B2
(en)
|
2012-11-05 |
2022-02-15 |
Surmodics, Inc. |
Compositions and methods for delivery of hydrophobic active agents
|
WO2014071387A1
(en)
|
2012-11-05 |
2014-05-08 |
Surmodics, Inc. |
Composition and method for delivery of hydrophobic active agents
|
WO2014167440A1
(en)
|
2013-03-26 |
2014-10-16 |
Wockhardt Limited |
Modified release pharmaceutical compositions of cyclobenzaprine or salts thereof
|
JP6649250B2
(ja)
|
2013-05-21 |
2020-02-19 |
プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ |
操作されたヘム結合性構成物およびその使用
|
FR3007972B1
(fr)
|
2013-07-04 |
2015-08-07 |
Oreal |
Composition cosmetique comprenant des esters gras liquides, des huiles volatiles et des epaississants, et procede de traitement cosmetique
|
EP3019522B1
(de)
|
2013-07-10 |
2017-12-13 |
Sutro Biopharma, Inc. |
Antikörper mit mehreren ortsspezifischen nichtnatürlichen aminosäureresten, verfahren zu deren herstellung und verfahren zu deren verwendung
|
US9840493B2
(en)
|
2013-10-11 |
2017-12-12 |
Sutro Biopharma, Inc. |
Modified amino acids comprising tetrazine functional groups, methods of preparation, and methods of their use
|
WO2015095604A2
(en)
|
2013-12-18 |
2015-06-25 |
President And Fellows Of Harvard College |
Methods and assays relating to circulating tumor cells
|
WO2015150948A1
(en)
|
2014-03-29 |
2015-10-08 |
Wockhardt Limited |
Modified release solid oral pharmaceutical compositions of cyclobenzaprine or a salt thereof
|
WO2016040347A2
(en)
|
2014-09-08 |
2016-03-17 |
University Of Iowa Research Foundation |
Microrna inhibitor system and methods of use thereof
|
ES2761558T3
(es)
|
2014-09-30 |
2020-05-20 |
Allergan Ind Sas |
Composiciones de hidrogel estables que incluyen aditivos
|
JP6702962B2
(ja)
|
2014-10-24 |
2020-06-03 |
ブリストル−マイヤーズ スクイブ カンパニーBristol−Myers Squibb Company |
改変fgf−21ポリペプチドおよびその使用
|
WO2016128783A1
(en)
|
2015-02-09 |
2016-08-18 |
Allergan Industrie Sas |
Compositions and methods for improving skin appearance
|
US10531957B2
(en)
|
2015-05-21 |
2020-01-14 |
Musculoskeletal Transplant Foundation |
Modified demineralized cortical bone fibers
|
EP3331549B1
(de)
|
2015-08-06 |
2020-12-23 |
President and Fellows of Harvard College |
Verbesserte mikrobenbindende moleküle und verwendungen davon
|
US10273476B2
(en)
|
2016-04-30 |
2019-04-30 |
University Of Iowa Research Foundation |
MicroRNA-200 based approaches for modulating bone formation inhibition and bone regeneration
|
RU2617049C1
(ru)
*
|
2016-05-12 |
2017-04-19 |
Федеральное государственное бюджетное учреждение "Национальный исследовательский центр "Курчатовский институт" |
Противоопухолевое лекарственное средство на основе никлозамида
|
US10898446B2
(en)
|
2016-12-20 |
2021-01-26 |
Surmodics, Inc. |
Delivery of hydrophobic active agents from hydrophilic polyether block amide copolymer surfaces
|
CN110637027A
(zh)
|
2017-02-08 |
2019-12-31 |
百时美施贵宝公司 |
包含药代动力学增强子的修饰的松弛素多肽及其用途
|
CN112351992A
(zh)
|
2017-12-20 |
2021-02-09 |
阿勒根公司 |
肉毒杆菌毒素细胞结合结构域多肽及其用于皮肤再生的方法
|
PL3849614T3
(pl)
|
2018-09-11 |
2024-04-22 |
Ambrx, Inc. |
Koniugaty polipeptydu interleukiny-2 i ich zastosowania
|
JP2022512746A
(ja)
|
2018-10-19 |
2022-02-07 |
アンブルックス,インコーポレイテッド |
インターロイキン-10ポリペプチド複合体、その二量体、およびそれらの使用
|
WO2020168017A1
(en)
|
2019-02-12 |
2020-08-20 |
Ambrx, Inc. |
Compositions containing, methods and uses of antibody-tlr agonist conjugates
|
JP2023517595A
(ja)
|
2020-03-11 |
2023-04-26 |
アンブルックス,インコーポレイテッド |
インターロイキン-2ポリペプチド結合物およびその使用方法
|
US20230302150A1
(en)
|
2020-08-20 |
2023-09-28 |
Ambrx, Inc. |
Antibody-tlr agonist conjugates, methods and uses thereof
|
KR20240004342A
(ko)
|
2021-04-03 |
2024-01-11 |
암브룩스, 인코포레이티드 |
항-her2 항체-약물 접합체 및 이의 용도
|